FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to composition for treatment of malignant neoplasm in patient, which contains epothilone - (1S, 3S, 7S, 10R, 11S, 12S, 16K)-7,11-dihydroxy-3-(2-methyl-benzotiasol-5-yl)-10-(prop-2-en-1-yl)-8,8,12,16-tetramethyl-4,17-dioxabicyclo[14.1.0]heptadecan-5,9-dion, hydroxypropyl-β-cyclodextrine or simple sulphobutyl ether of β-cyclodextrine and fillers, selected from mannitol and trometamol. Invention also relates to method of claimed composition obtaining, which includes dissolving epothilone in alcohol, dissolving hydroxypropyl-β-cyclodextrine or simple sulphobuthyl ether of β-cyclodextrine in water solution together with mannitol and trometamol, bringing pH of water solution to value 5-9 by means of hydrochloric acid and mixing obtained solutions.
EFFECT: invention also relates to method of malignant neoplasm treatment in patient, which includes intravenous infusion of claimed composition during period of approximately 30 minutes in dose from 10 mg/m2 to 35 mg/m2.
17 cl, 11 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF EPOTHILONES IN TREATMENT OF BRAIN DISEASES ASSOCIATED WITH PROLIFERATIVE PROCESSES | 2003 |
|
RU2351330C2 |
MODIFIED C-21-EPOTHILONES | 2000 |
|
RU2253652C2 |
DERIVATIVES OF EPOTHILONE | 1998 |
|
RU2213741C2 |
EPOTHILONE DERIVATIVE FOR TREATMENT OF HEPATOME AND OTHER CANCER DISEASES | 2003 |
|
RU2358730C2 |
POLYMORPHIC MODIFICATIONS OF EPOTILONE ANALOG, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2001 |
|
RU2272039C2 |
SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2001 |
|
RU2264217C2 |
MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
METHOD FOR INTRODUCING EPOTILONE ANALOGS FOR TREATING CANCER CASES | 2002 |
|
RU2292202C2 |
PLADIENOLIDE DERIVATIVES AS DRUGS WITH TARGETED INFLUENCE ON SPLICEOSOME FOR TREATMENT OF CANCER | 2019 |
|
RU2815064C2 |
METHOD FOR IDENTIFICATION OF ANTI-TUMOR TARGET ENZYMES | 2002 |
|
RU2319482C2 |
Authors
Dates
2011-04-20—Published
2005-12-20—Filed